Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Have Conflicting Sentiments on These Healthcare Companies: Ovid Therapeutics (OVID) and Hologic (HOLX)

Tipranks - Tipranks - Sat Mar 28, 6:24AM CDT

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ovid Therapeutics (OVID) and Hologic (HOLX).

Claim 30% Off TipRanks Premium

Ovid Therapeutics (OVID)

In a report released yesterday, Thomas Shrader from BTIG maintained a Buy rating on Ovid Therapeutics, with a price target of $4.00. The company’s shares closed last Thursday at $2.46.

According to TipRanks.com, Shrader is a 4-star analyst with an average return of 6.1% and a 39.9% success rate. Shrader covers the Healthcare sector, focusing on stocks such as Coya Therapeutics, Inc., Alto Neuroscience, Inc., and Acumen Pharmaceuticals. ;'>

Ovid Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $4.72, which is a 100.9% upside from current levels. In a report issued on March 18, TD Cowen also maintained a Buy rating on the stock.

See today’s best-performing stocks on TipRanks >>

Hologic (HOLX)

In a report released yesterday, Ryan Zimmerman from BTIG maintained a Hold rating on Hologic. The company’s shares closed last Thursday at $75.69.

According to TipRanks.com, Zimmerman is a 1-star analyst with an average return of -0.4% and a 40.0% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as GE Healthcare Technologies Inc, Shoulder Innovations, Inc., and Tactile Systems Technology. ;'>

Hologic has an analyst consensus of Hold, with a price target consensus of $78.00.

Read More on OVID:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).